CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL

The study investigated the effects of cardiac cytoprotectors – mildronate and trimetazidine, combined with ACE therapy, on lipid peroxidation product levels, endothelial function, circadian blood pressure (BP) profile, left ventricular myocardium, and intracardiac hemodynamics in patients with arter...

Full description

Saved in:
Bibliographic Details
Main Authors: F. E. Khebodarov, V. P. Mikhin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2009-10-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1386
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850026992422879232
author F. E. Khebodarov
V. P. Mikhin
author_facet F. E. Khebodarov
V. P. Mikhin
author_sort F. E. Khebodarov
collection DOAJ
description The study investigated the effects of cardiac cytoprotectors – mildronate and trimetazidine, combined with ACE therapy, on lipid peroxidation product levels, endothelial function, circadian blood pressure (BP) profile, left ventricular myocardium, and intracardiac hemodynamics in patients with arterial hypertension (AH). It was demonstrated that in AH patients, the combination of mildronate and enalapril facilitated lipid peroxidation reduction, endothelial function and circadian BP normalization, as well as improvement of left ventricular morphology and function. The combination of trimetazidine and enalapril did not improve the effectiveness of antihypertensive therapy.
format Article
id doaj-art-b5e9ed0e050c4d718d567946dc7b6df6
institution DOAJ
issn 1560-4071
2618-7620
language Russian
publishDate 2009-10-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-b5e9ed0e050c4d718d567946dc7b6df62025-08-20T03:00:22Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202009-10-010546501175CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRILF. E. Khebodarov0V. P. Mikhin1ФГУЗ – Медсанчасть УВД по Курской области, КурскКурский государственный медицинский университет, кафедра внутренних болезней № 2The study investigated the effects of cardiac cytoprotectors – mildronate and trimetazidine, combined with ACE therapy, on lipid peroxidation product levels, endothelial function, circadian blood pressure (BP) profile, left ventricular myocardium, and intracardiac hemodynamics in patients with arterial hypertension (AH). It was demonstrated that in AH patients, the combination of mildronate and enalapril facilitated lipid peroxidation reduction, endothelial function and circadian BP normalization, as well as improvement of left ventricular morphology and function. The combination of trimetazidine and enalapril did not improve the effectiveness of antihypertensive therapy.https://russjcardiol.elpub.ru/jour/article/view/1386arterial hypertensioncardiac cytoprotectorsenalapril
spellingShingle F. E. Khebodarov
V. P. Mikhin
CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL
Российский кардиологический журнал
arterial hypertension
cardiac cytoprotectors
enalapril
title CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL
title_full CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL
title_fullStr CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL
title_full_unstemmed CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL
title_short CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL
title_sort cytoprotector role in the management of arterial hypertension treated with enalapril
topic arterial hypertension
cardiac cytoprotectors
enalapril
url https://russjcardiol.elpub.ru/jour/article/view/1386
work_keys_str_mv AT fekhebodarov cytoprotectorroleinthemanagementofarterialhypertensiontreatedwithenalapril
AT vpmikhin cytoprotectorroleinthemanagementofarterialhypertensiontreatedwithenalapril